Refemoline 0.1%+0.025% is a Product of the Generic Fluorometholone + Tetrahydrozoline

Refemoline 0.1%+0.025% belongs to the generic category of Fluorometholone + Tetrahydrozoline. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Refemoline 0.1%+0.025%. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Fluorometholone + Tetrahydrozoline and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Refemoline 0.1%+0.025%

Refemoline 0.1%+0.025% may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Refemoline 0.1%+0.025% is provided below to help users gain a clear understanding of this medicine.

What Is Refemoline 0.1%+0.025% Indications and Uses?

This preparation eye drop is indicated in-

Acute and chronic allergic non-infectious conjunctivitis and keratitis with severe swelling and intravascular injection
Non-infectious inflammation of the anterior segment of the eye (including anterior uveitis, episcleritis and scleritis)
Post-operative irritative conditions after strabismus; cataract & glaucoma surgery with supplementary antimicrobial therapy.

Pharmacology (Source, Chemical and Physical Composition) Of Refemoline 0.1%+0.025%

Fluorometholone is thought to act by the induction of phospholipase A2 inhibitory proteins which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. On the other hand, Tetrahydrozoline is an alpha agonist which constricts the conjunctival blood vessels and thereby relieves the redness of the eye.

Dosage And Administration of Refemoline 0.1%+0.025%

Use in adult: Instill 1 drop into the conjunctival sac 2-3 times daily. The dose may be increased for severe and adult patient to 1 drop hourly for first one to two days.Use in children: Safety & effectiveness in children below 2 years of age have not been established.

Drug Interactions of Refemoline 0.1%+0.025%

Tetrahydrozoline may interact with antidepressant drugs which inhibits Mono Amino Oxidase (MAO) Enzyme such as Isocarboxazid, phenelzine and its sulphate derivative, Toloxatone, Tranylcypromine and its sulphate derivative etc.

Side Effects of Refemoline 0.1%+0.025%

Mild burning sensation, reversible increase in intraocular pressure, reactive hyperemia, cataract & corneal defects, glaucoma, systemic effects (chronic use).

Use During Pregnancy and Lactation

There are no adequate and well-controlled studies of Fluorometholone & Tetrahydrozoline in pregnancy or while breast-feeding. Therefore, this combination should be used during pregnancy only if the potential benefits justify the potential risk to the fetus.

Precautions And Warnings for Refemoline 0.1%+0.025%

Avoid prolonged use. This preparation should be used after a careful risk benefit evaluation in case of patients with severe blood circulation diseases, metabolic disturbances, under treatment with MAOIs & other potentially hypertensive drugs, history of cataract, herpes simplex infection, rhinitis sicca.

Therapeutic Class

Ophthalmic Steroid preparations

Storage Conditions of It

Keep out of the reach of children. Store in a cool, dry place, away from heat and direct light. Do not use more than 4 weeks after opening.

Refemoline 0.1%+0.025% is a Product of the Generic Fluorometholone + Tetrahydrozoline